“Bioidentical” gets used as if it were a safety rating. It is not. It is a chemistry word: the hormone in the bottle has the same molecular structure as the estradiol, progesterone, or testosterone a human ovary or testis already makes.
“Synthetic” gets used as a smear. That is sloppy too. Some older products are chemically different from human hormones on purpose. Some products people call synthetic are FDA-approved medicines with decades of outcome data. Some products people call bioidentical are compounded in a pharmacy for one patient and have never been through an FDA approval trial.
If you are comparing BHRT for women in Lakeway with what a friend was prescribed in 2003, you need those distinctions before you pick a clinic. This article does not invent Women’s Health Initiative percentages. For the broader safety question, start with Is hormone replacement therapy safe?.
What bioidentical means
A bioidentical hormone matches the molecule the body makes. Estradiol is estradiol. Micronized progesterone is progesterone. Testosterone is testosterone. ACOG describes these hormones as plant-derived. That is a starting material, not a safety claim, and “natural” is not a medical category.
The American College of Obstetricians and Gynecologists (ACOG), in a 2023 clinical consensus, uses a similar definition: bioidentical hormones are chemically similar or structurally identical to those produced by the body. ACOG also points out that the word covers two different shelves. One shelf is commercially manufactured, FDA-approved products (estradiol patches and gels, oral micronized progesterone, and others). The other shelf is custom-compounded preparations that are not FDA-approved.
Thrive uses that same split on the bioidentical hormone therapy in Austin page. If Kristine Kjolhede, FNP-C, recommends a hormone, she will tell you which shelf it sits on.
Bioidentical does not mean risk-free. Every sex hormone is a real medicine. Dose, delivery, your uterus, your clotting history, and your age at start all change the conversation.
What people mean by synthetic
When patients say “synthetic HRT,” they usually mean older commercial classes.
Conjugated estrogens (often written CEE, conjugated equine estrogens) are a mixture of estrogens historically prepared from pregnant-mare urine. They bind estrogen receptors and they have been studied in large trials. They are not a single estradiol molecule.
Progestins are synthetic compounds that act on progesterone receptors. Medroxyprogesterone acetate (MPA) is the progestin that sat next to CEE in the trial most people still mean when they say “HRT was proven dangerous.” MPA is not micronized progesterone.
Some newer commercial products are bioidentical and FDA-approved. Oral micronized progesterone is one example ACOG lists. An estradiol patch is another. Calling those “synthetic” because a factory made them mixes up the categories.
The useful contrast is molecule (identical or analog), regulatory path (FDA-approved product or compounded product), and route.
FDA-approved product vs compounded product
An FDA-approved hormone product went through the agency’s process for that specific formulation: identity, strength, quality, and labeled indications. Package inserts carry risks and dosing. Adverse events have a reporting path.
A compounded hormone is mixed by a licensed pharmacy for one patient, from a prescription. Under U.S. compounding law, those preparations are exempt from the FDA-approval-before-marketing rules that apply to manufactured drugs. ACOG states that compounded products are not reviewed by the FDA for safety, effectiveness, or quality. That is a regulatory fact, not a verdict on every pharmacy.
Thrive compounds through the FarmaKeio network when a compounded preparation is the right call: a dose or form that is not sitting on a commercial shelf. Compounded does not mean unsupervised. It also does not mean the pellet or cream has the same outcome trial behind it that oral CEE plus MPA had.
ACOG’s 2023 consensus recommends FDA-approved menopausal hormone therapies when those formulations exist, and it says evidence is lacking for marketing claims that compounded bioidentical hormones are safer or more effective. Thrive will say that out loud, then decide with you. A compounded estradiol pellet has not been proven safer than an estradiol patch. A stock patch also does not fit every patient.
If you have a peanut allergy and the approved oral progesterone capsule uses peanut oil, compounding that hormone without peanut oil is a classic, narrow reason to compound. That example is ACOG’s. “I want it custom” is a preference. It is not, by itself, a medical indication.
Delivery route matters as much as the molecule
Oral estrogen is processed through the liver first. Transdermal estradiol (patch, gel, cream) is not. That difference shows up in how clotting factors and triglycerides are discussed. It is a reason many clinicians prefer a transdermal route for estradiol in some patients. It is not a trophy. Skin absorption varies. Patches fall off. Creams transfer to a partner, a child, or a dog if you are sloppy.
Pellets sit under the skin and release hormone for months. The dose is set once they are placed. You cannot wash a pellet off on a bad week. That is the trade: steadiness against flexibility.
Oral micronized progesterone at night is a common pairing with whatever carries the estrogen, in part because the uterus needs a progestogen if you still have one and you are taking systemic estrogen. Sleepiness is a reason some women like the oral route. It is not a reason to skip uterine protection.
No route wins on every count. Kristine will walk the trade-offs against your labs, your calendar, and whether you can keep a daily cream honest.
What the 2002 WHI actually studied, and what it did not
The account below is qualitative. An FDA consumer fact sheet and the 2002 JAMA results paper did not return a clean 200 fetch on this pass (citation pending). Two pages that did: the NHLBI Women’s Health Initiative project page, and the NIH dbGaP study record for the WHI clinical trial and observational study.
The Women’s Health Initiative is an NHLBI-sponsored program. The original study enrolled more than 161,000 postmenopausal women at 40 U.S. centers. The randomized hormone-therapy trials enrolled more than 68,000 women ages 50 to 79.
Women with an intact uterus were randomized to oral conjugated equine estrogens 0.625 mg per day plus medroxyprogesterone acetate 2.5 mg per day, or placebo. Women with a prior hysterectomy were randomized to CEE alone or placebo. The estrogen-plus-progestin trial was stopped early in July 2002. The estrogen-alone trial was stopped early in March 2004. Both stops were based on adverse effects. NHLBI’s public summary of those hormone trials is that hormone replacement therapy did not prevent heart disease in postmenopausal women as was once thought.
That is what was studied: older postmenopausal women, oral CEE, and (for women with a uterus) oral MPA, started for chronic-disease prevention, not as a first-line hot-flash clinic for someone near menopause in Lakeway.
What it did not study: transdermal estradiol, micronized progesterone, compounded pellets or creams, testosterone in women, or a head-to-head test of “bioidentical is safer.” It also did not isolate “start near menopause” versus “start at 70” as a pre-specified contest.
You cannot honestly say the WHI proved all HRT is dangerous. You also cannot say it proved BHRT is safe. This draft does not quote clot or breast-cancer percentages.
How Thrive decides
Thrive does not run a template. Kristine starts with labs, symptoms, and history, under physician supervision. BHRT for women in Lakeway is the women’s front door. Men have a separate workup.
Uterine protection is not optional theater. If you have a uterus and you take systemic estrogen, a progestogen belongs in the plan unless there is a specific reason it does not. That reason gets said out loud.
EvexiPEL enters when pellets fit: a patient who wants a steady, low-level release and who can live with a dose that is set at insertion. EvexiPEL-certified means the insertion method and the dosing approach, not a guarantee of how you will feel in week three.
FarmaKeio compounding enters when the prescription needs a dose or form that a commercial bottle does not offer. “Compounded at FarmaKeio” is a pharmacy path. It is not a clinical outcome.
Follow-up labs are part of the product. A prescription without a recheck is how people end up over-replaced or under-replaced and blaming the molecule. Some histories (certain hormone-sensitive cancers, unexplained vaginal bleeding, active clotting disease) mean the answer is no, or the answer is coordination with another physician. Kristine will say no.
Pellets, creams, and oral progesterone
Pellets are tiny custom-compounded implants of estradiol and/or testosterone, placed just under the skin in the Lakeway office. They release a low, steady amount for months. Nothing to remember day to day, and no transfer risk on the skin. The dose cannot be dialed down without waiting out the pellet, which is why the pre-insertion labs matter.
Creams and gels are daily and easy to change. Absorption varies with skin, application site, and whether you washed it off. Transfer to other people and pets is a real instruction, not fine print.
Oral progesterone is most often taken at night when a woman needs uterine protection or when sleep is part of the complaint. It is commonly paired with a non-oral estrogen. It is not a substitute for evaluating sleep apnea if that is the actual problem.
Methods can be combined and they can change. There is no best method, only the one that fits this month’s labs and life. Injections and commercial patches exist; if they fit, they get named in the visit.
How to choose a Lakeway or Austin clinic
Ask who the named provider is. At Thrive it is Kristine Kjolhede, FNP-C, EvexiPEL-certified, physician-supervised, in Lakeway. If a website will not put a license on the page, look elsewhere.
Ask how they monitor. “We do BHRT” without a lab schedule is a product, not a practice. Ask which pharmacy, and whether a recommendation is an FDA-approved product or a compounded one. You are allowed to hear that sentence in plain English.
Thrive is in Lakeway and sees people from Bee Cave, Westlake, Spicewood, and greater Austin. Clinic hours are Tuesday through Thursday in office. Friday through Monday the office is closed. The patient portal is thrive.esprehealth.com. The phone is (737) 242-6722.
Skip a clinic that promises bioidentical hormones have no risks, or that treats the 2002 WHI as either a ban on all estrogen or a rumor you can ignore. Hormone care that starts with a pellet and no labs is the wrong kind of simple.
Service pages: BHRT for women in Lakeway and bioidentical hormone therapy in Austin. Safety question in shorter form: Is hormone replacement therapy safe?. This article is educational. It is not medical advice, and it does not start a prescription.
Sources (fetch-verified 200)
- NIH dbGaP, Women’s Health Initiative Clinical Trial and Observational Study (phs000200): https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000200.v8.p2
- NHLBI, Women’s Health Initiative project page: https://www.nhlbi.nih.gov/science/womens-health-initiative-whi
- ACOG Clinical Consensus No. 6 (November 2023), Compounded Bioidentical Menopausal Hormone Therapy: https://www.acog.org/clinical/clinical-guidance/clinical-consensus/articles/2023/11/compounded-bioidentical-menopausal-hormone-therapy
- Thrive BHRT for women: https://www.thrivehormonalhealth.com/hormone-therapy/women/bhrt-women/
- Thrive Austin BHRT: https://www.thrivehormonalhealth.com/bioidentical-hormone-therapy-austin/
- Thrive, Is hormone replacement therapy safe? (6 August 2026): https://www.thrivehormonalhealth.com/2026/08/06/is-hormone-replacement-therapy-safe/
This article is for educational purposes and is not medical advice, a diagnosis, or a treatment recommendation. Individual results vary. Always consult a qualified healthcare provider before starting any treatment. Kristine Kjolhede, FNP-C, reads these cases with physician supervision.